Luye Pharma Group Ltd Stock Singapore S.E.
Equities
LUYE
BMG5722Z1014
Pharmaceuticals
Sales 2024 * | 6.83B 945M 1.28B | Sales 2025 * | 7.81B 1.08B 1.47B | Capitalization | 10.36B 1.43B 1.94B |
---|---|---|---|---|---|
Net income 2024 * | 677M 93.7M 127M | Net income 2025 * | 965M 134M 181M | EV / Sales 2024 * | 1.9 x |
Net Debt 2024 * | 2.59B 359M 486M | Net Debt 2025 * | 2.41B 333M 452M | EV / Sales 2025 * | 1.64 x |
P/E ratio 2024 * |
16.1
x | P/E ratio 2025 * |
12.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.84% |
Managers | Title | Age | Since |
---|---|---|---|
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Yun Li Xue
PRN | Corporate Officer/Principal | 60 | 94-06-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hui Xian Yuan
BRD | Director/Board Member | 65 | 94-06-07 |
Rong Bing Yang
PSD | President | 58 | 94-06-07 |
Dian Bo Liu
CEO | Chief Executive Officer | 59 | 03-07-01 |
1st Jan change | Capi. | |
---|---|---|
+32.95% | 700B | |
+26.51% | 569B | |
-4.97% | 358B | |
+18.83% | 330B | |
+3.54% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.70% | 161B |